Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases
Open Access
- 13 February 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 12 (3) , 852-861
Abstract
The biosynthetic and catabolic enzymes of the endocannabinoids tightly regulate endocannabinoid-mediated activation of the cannabinoid CB1 receptor. Monitoring the activities of these endocannabinoid hydrolases in different brain regions is, therefore, key to gaining insight into spatiotemporal control of CB1 receptor-mediated physiology. We have employed a comparative chemical proteomics approach to quantitatively map the activity profile of endocannabinoid hydrolases in various mouse brain regions at the same time. To this end, we used two different activity-based probes: fluorophosphonate-biotin (FP-biotin), which quantifies FAAH, ABHD6, and MAG-lipase activity, and MB108, which detects DAGL-α, ABHD4, ABHD6, and ABHD12. In total, 32 serine hydrolases were evaluated in the frontal cortex, hippocampus, striatum, and cerebellum. Comparison of endocannabinoid hydrolase activity in the four brain regions revealed that FAAH activity was highest in the hippocampus, and MAGL activity was most pronounced in the frontal cortex, whereas DAGL-α was most active in the cerebellum. Comparison of the activity profiles with a global proteomics data set revealed pronounced differences. This could indicate that post-translational modification of the endocannabinoid hydrolases is important to regulate their activity. Next, the effect of genetic deletion of the CB1 receptor was studied. No difference in the enzymatic activity was found in the cerebellum, striatum, frontal cortex, and hippocampus of CB1 receptor knockout animals compared to wild type mice. Our results are in line with previous reports and indicate that the CB1 receptor exerts no regulatory control over the basal production and degradation of endocannabinoids and that genetic deletion of the CB1 receptor does not induce compensatory mechanisms in endocannabinoid hydrolase activity.Keywords
This publication has 48 references indexed in Scilit:
- More surprises lying ahead. The endocannabinoids keep us guessingNeuropharmacology, 2014
- The Endocannabinoid System and the BrainAnnual Review of Psychology, 2013
- Cannabinoid CB1receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cellsBritish Journal of Pharmacology, 2011
- Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelightNature Neuroscience, 2010
- Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out MiceThe Journal of Neuroscience, 2010
- The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic TransmissionNeuron, 2010
- Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous SystemChemical Reviews, 2008
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- The endocannabinoid system and its therapeutic exploitationNature Reviews Drug Discovery, 2004
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002